- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A consultant complained about unsolicited Grazax emails. PMCPA found no explicit opt-in for promotional email and that launch-period mailing limits were exceeded…
A GP challenged ‘Curing Allergy’ on an EpiPen Dear Doctor letter. PMCPA said even as part of a logo it was a…
Intercompany complaint about Gardasil journal ad claims on cervical cancer prevention and “Benefit from 4 types”. Panel concerns on ambiguity were superseded…
Complaint alleged Novo Nordisk’s out-of-hours diabetes helpline (for users of its products) improperly incentivised nurses who also worked in NHS clinics. PMCPA…
A GP journal ad for Acomplia was ruled misleading: it implied use in all overweight patients and suggested broad cardiometabolic benefits beyond…
Sunday Times alleged nurses were paid/bonused to influence prescribing. Panel found most audits acceptable, but breached the Code where a nurse programme…
A pharmacist alleged a Seqirus promotional email about Fluad implied JCVI policy had changed to recommend Fluad for all 65+. Panel found…
PMCPA case AUTH/2762/5/15 (Director v Astellas) about clinical trial disclosure for Betmiga. The matter was ruled outwith the scope of the Code…
PMCPA case AUTH/3016/1/18 (2016 Code): complaint by a consultant haematologist alleging religious discrimination against Takeda. Outcome: no breach; matter found outwith the…
Financial Times alleged AstraZeneca delayed disclosing patient group funding. PMCPA held website vs annual report disclosure are alternatives under Clause 20.3; AstraZeneca’s…
Complaint about celebrity comments praising Levitra in BBC and Saga online articles linked to SortEDin10. PMCPA ruled celebrity endorsement isn’t prohibited per…
Appeal Board found “24-hour glycaemic control” claims for Lantus exaggerated and misleading: once-daily basal insulin action did not equal 24-hour glycaemic control.…
A Qvar leavepiece claimed “Twice as many symptom-free days” vs CFC-BDP. PMCPA found the pharmacoeconomic analysis cited wasn’t robust enough for such…
A COPD ad featuring a prominent “NICE 2018” badge and Anoro imagery was ruled misleading, implying NICE recommended Anoro and implying an…
Anonymous complaint alleged a Code breach for sponsoring a meeting at a football club. Panel found the venue acceptable given delegate numbers,…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.